Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non–small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective Study

Autor: Luciani, Andrea, Marra, Antonio, Toschi, Luca, Cortinovis, Diego, Fava, Sergio, Filipazzi, Virginio, Tuzi, Alessandro, Cerea, Giulio, Rossi, Sabrina, Perfetti, Vittorio, Rossi, Antonio, Giannetta, Laura, Sala, Luca, Finocchiaro, Giovanna, Pizzutilo, Elio Gregory, Carelli, Stephana, Agustoni, Francesco, Cergnul, Massimiliano, Zonato, Sabrina, Siena, Salvatore, Bidoli, Paolo, Ferrari, Daris
Zdroj: In Clinical Lung Cancer November 2020 21(6):e567-e571
Databáze: ScienceDirect
Externí odkaz: